This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Second Sight Medical Products Management

Management criteria checks 3/4

Key information

Scott Dunbar

Chief executive officer

US$301.4k

Total compensation

CEO salary percentage	77.82%
CEO tenure	1.4yrs
CEO ownership	0.006%
Management average tenure	no data
Board average tenure	7.1yrs

Recent management updates

No updates

Recent updates

Second Sight, Nano Precision complete merger, renaming as Vivani Medical

Aug 30

Second Sight Medical sheds ~17% after reverse stock split

Aug 19

Second Sight stock rises as shareholders approve merger, name change, reverse stock split

Jul 29

Second Sight stock rises ~10% on $1.1M funding from NIH for artificial vision implant trial

Jul 18

Revisiting Second Sight Medical Products: The EV Is Negative And Being Short No Longer Looks Appealing

Mar 22

CEO Compensation Analysis

How has Scott Dunbar's remuneration changed compared to Second Sight Medical Products's earnings?
Date	Total Compensation	Salary	Company Earnings
Jun 30 2022	n/a	n/a	-US$9m
Mar 31 2022	n/a	n/a	-US$8m
Dec 31 2021	US$301k	US$235k	-US$9m
Sep 30 2021	n/a	n/a	-US$9m
Jun 30 2021	n/a	n/a	-US$8m
Mar 31 2021	n/a	n/a	-US$9m
Dec 31 2020	US$342k	US$255k	-US$15m

Compensation vs Market: Scott's total compensation ($USD301.39K) is below average for companies of similar size in the US market ($USD764.69K).

Compensation vs Earnings: Scott's compensation has been consistent with company performance over the past year.

CEO

Scott Dunbar (64 yo)

1.4yrs

Tenure

US$301,389

Compensation

Mr. Scott Dunbar has been Acting Chief Executive Officer at Second Sight Medical Products, Inc since March 26, 2021. For many years he served Second Sight as Patent Counsel, Senior Patent Counsel, and Seni...

Board Members

Name	Position	Tenure	Compensation	Ownership
Matthew Pfeffer	Independent Director	7.3yrs	US$55.00k	0.038% $ 20.4k
Aaron Mendelsohn	Independent Director	24.6yrs	US$59.00k	0% $ 0
Gregg Williams	Independent Non-Executive Chairman	13.2yrs	US$54.00k	19.28% $ 10.5m
Jonathan McGuire	Director	7yrs	US$35.00k	0.052% $ 28.2k
Dean Baker	Independent Director	1.3yrs	US$59.00k	no data
Alexandra Larson	Independent Director	1.3yrs	US$35.00k	0.0013% $ 690.7

7.1yrs

Average Tenure

63.5yo

Average Age

Experienced Board: EYES's board of directors are considered experienced (7.1 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/08/30 00:54
End of Day Share Price	2022/08/30 00:00
Earnings	2022/06/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Second Sight Medical Products, Inc. is covered by 3 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kyle Bauser	Colliers Securities
Amit Dayal	H.C. Wainwright & Co.
Michael Higgins	Rodman & Renshaw, LLC